Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa

Clinical and Experimental Medicine

Volumn 15, Issue 4, 2015, Pages 447-454

  Vincentini, Olimpia ^a   Maialetti, Francesca ^a   Gonnelli, Elena ^a   Silano, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Celiac disease; Gliadin peptides; In vitro model

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLIADIN; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD; CELIAC DISEASE; CELL ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEAMINATION; FEMALE; GOLD STANDARD; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; ADAPTIVE IMMUNITY; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL CULTURE TECHNIQUE; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ADOLESCENT; CELIAC DISEASE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHILD; CYTOKINES; EPITHELIAL CELLS; FEMALE; GLIADIN; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; MALE; MODELS, BIOLOGICAL; MONOCYTES;

EID: 84945476150     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-014-0325-2     Document Type: Article

References (28)

1. Meresse B, Malamut G, Cerf-Bensussan N. Celiac disease: an immunological jigsaw. Immunity. 2012;36:907–19.
2. Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol. 2013;13:294–302.
3. Jabri B, Kasarda DD, Green PH. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev. 2005;206:219–31.
4. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–7.
5. Maiuri L, Ciacci C, Ricciardelli I, et al. Unexpected role of surface transglutaminase type II in celiac disease. Gastroenterology. 2005;129:1400–13.
6. Petersen J, Montserrat V, Mujico JR, et al. T-cell receptor recognition of HLA-DQ2–gliadin complexes associated with celiac disease. Nat Struct Mol Biol. 2014;21:480–8.
7. Tollefsen S, Arentz-Hansen H, Fleckenstein B, et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest. 2006;116:2226–36.
8. Sollid LM, Jabri B. Celiac disease and transglutaminase 2: a model for post-translational modification of antigens and HLA association in the pathogenesis of autoimmune disorders. Curr Opin Immunol. 2011;23:732–8.
9. Forsberg G, Hernell O, Melgar S, et al. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology. 2002;123:667–78.
10. Nilsen EM, Jahnsen FL, Lundin KE, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology. 1998;115:551–63.
11. Garrote JA, Gómez-González E, Bernardo D, Arrantz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr. 2008;47:S27–32.
12. Nanayakkara M, Lania G, Maglio M, et al. An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease. Am J Clin Nutr. 2013;98:1123–35.
13. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology. 2009;137:1912–33.
14. Salvati VM, Mazzarella G, Gianfrani C, et al. Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut. 2005;54:46–53.
15. Lindfors K, Rauhavirta T, Stenman S, Mäki M, Kaukinen K. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options. Exp Biol Med. 2012;237:119–25.
16. Silano M, Vincentini O, Luciani A, et al. Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin—dependent agglutination. Pediatr Res. 2012;71:532–8.
17. De Palma G, Kamanova J, Cinova JL, et al. Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease. J Leukoc Biol. 2012;92:1043–54.
18. Luciani A, Villella VR, Vasaturo A, et al. Lysosomal accumulation of gliadin p31–43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa. Gut. 2010;59:311–9.
19. Barone MV, Zanzi D, Maglio M, et al. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One. 2011;6:e17039.
20. Pagliari D, Cianci R, Frosali S, et al. The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev. 2013;24:455–66.
21. DePaolo RW, Abadie V, Tang F, et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature. 2011;471:220–34.
22. Camarca A, Radano G, Di Mase R, et al. Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten. Clin Exp Immunol. 2012;169:129–36.
23. Lammi A, Arikoski P, Vaarala O, Kinnunen T, Ilonen J. Increased peripheral blood CD4+ T cell responses to deamidated but not to native gliadin in children with coeliac disease. Clin Exp Immunol. 2012;168:207–14.
24. Esposito C, Paparo F, Caputo I, et al. Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol. 2003;8:1813–20.
25. Tack GJ, van Wanrooij RL, Von Blomberg BM, et al. Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing–a cohort study. BMC Gastroenterol. 2012;12:159.
26. Kalliomäki M, Satokari R, Lähteenoja H, et al. Expression of microbiota, toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr. 2012;54:727–32.
27. Lammers KM, Khandelwal S, Chaudhry F, et al. Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology. 2011;132:432–40.
28. Vincentini O, Quaranta MG, Viora M, Agostoni C, Silano M. Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA2. Clin Nutr. 2011;30:541–6.